Taking a Break From Huntingtin

by Davidson, Beverly L
Published 2012

CRISPR to the Rescue: Advances in Gene Editing for the FMR1 Gene

by Yrigollen, Carolyn M., Davidson, Beverly L.
Published 2019

Gene therapy for ALS: A review

by Amado, Defne A., Davidson, Beverly L.
Published 2021

Current prospects for RNA interference-based therapies

by Davidson, Beverly L., McCray, Paul B.
Published 2011

Unique molecular signatures of disease brain endothelia provide a novel site for CNS-directed enzyme therapy

by Chen, Yong Hong, Chang, Michael, Davidson, Beverly L
Published 2009

Gene Silencing Mediated by siRNA-binding Fusion Proteins Is Attenuated by Double-stranded RNA-binding Domain Structure

by Geoghegan, James C, Gilmore, Brian L, Davidson, Beverly L
Published 2012

Overcoming Limitations Inherent in Sulfamidase to Improve Mucopolysaccharidosis IIIA Gene Therapy

by Chen, Yonghong, Zheng, Shujuan, Tecedor, Luis, Davidson, Beverly L.
Published 2018

Temporal Phenotypic Changes in Huntington’s Disease Models for Preclinical Studies

by St-Cyr, Sophie, Smith, Alicia R., Davidson, Beverly L.
Published 2022

MiR-34a Represses Numbl in Murine Neural Progenitor Cells and Antagonizes Neuronal Differentiation

by Fineberg, Sarah K., Datta, Poppy, Stein, Colleen S., Davidson, Beverly L.
Published 2012

CRISPR/Cas9 Editing of the Mutant Huntingtin Allele In Vitro and In Vivo

by Monteys, Alex Mas, Ebanks, Shauna A., Keiser, Megan S., Davidson, Beverly L.
Published 2017

Combined overexpression of ATXN1L and mutant ATXN1 knockdown by AAV rescue motor phenotypes and gene signatures in SCA1 mice

by Carrell, Ellie M., Keiser, Megan S., Robbins, Ashley B., Davidson, Beverly L.
Published 2022

CLN3 Deficient Cells Display Defects in the ARF1-Cdc42 Pathway and Actin-Dependent Events

by Schultz, Mark L., Tecedor, Luis, Stein, Colleen S., Stamnes, Mark A., Davidson, Beverly L.
Published 2014

RNAi prevents and reverses phenotypes induced by mutant human ataxin‐1

by Keiser, Megan S., Monteys, Alejandro Mas, Corbau, Romuald, Gonzalez‐Alegre, Pedro, Davidson, Beverly L.
Published 2016

In vivo SELEX for Identification of Brain-penetrating Aptamers

by Cheng, Congsheng, Chen, Yong Hong, Lennox, Kim A, Behlke, Mark A, Davidson, Beverly L
Published 2013

Modulating membrane fluidity corrects Batten disease phenotypes in vitro and in vivo

by Schultz, Mark L., Tecedor, Luis, Lysenko, Elena, Ramachandran, Shyam, Stein, Colleen S., Davidson, Beverly L.
Published 2018

Platelet Activating Factor Receptor Activation Improves siRNA Uptake and RNAi Responses in Well-differentiated Airway Epithelia

by Krishnamurthy, Sateesh, Behlke, Mark A, Apicella, Michael A, McCray, Paul B, Davidson, Beverly L
Published 2014

Chondroitin Sulfate is the Primary Receptor for a Peptide-Modified AAV That Targets Brain Vascular Endothelium In Vivo

by Geoghegan, James C, Keiser, Nicholas W, Okulist, Anna, Martins, Inês, Wilson, Matthew S, Davidson, Beverly L
Published 2014

Standard screening methods underreport AAV-mediated transduction and gene editing

by Lang, Jonathan F., Toulmin, Sushila A., Brida, Kasey L., Eisenlohr, Laurence C., Davidson, Beverly L.
Published 2019

Infection of Human Airway Epithelia with H1N1, H2N2, and H3N2 Influenza A Virus Strains

by Slepushkin, Vladimir A., Staber, Patrick D., Wang, Guoshun, McCray, Paul B., Davidson, Beverly L.
Published 2001

DeepRepeat: direct quantification of short tandem repeats on signal data from nanopore sequencing

by Fang, Li, Liu, Qian, Monteys, Alex Mas, Gonzalez-Alegre, Pedro, Davidson, Beverly L., Wang, Kai
Published 2022